Clinical Trials Search
Clinical Trial 19067
Cancer Type: Thoracic
Interventions:CRS-207; Pembrolizumab (Keytruda)
Study Type: Treatment
Phase of Study: Phase II
- Tawee Tanvetyanon
A Phase 2 Single-arm Study to Evaluate Safety and Efficacy of CRS-207 with Pembrolizumab in Adults with Previously-Treated Malignant Pleural Mesothelioma
The purpose of this study is to evaluate whether CRS-207 with pembrolizumab is safe and effective in adults with MPM who have failed prior anti-cancer therapy.
Assess safety and tolerability of CRS-207 and pembrolizumab. Evaluate the effect of CRS-207 and pembrolizumab on tumor response, pulmonary function, and survival. Characterize the immune response following administration of CRS-207 and pembrolizumab.